Ken C.

Ken C. is an accomplished professional with extensive experience in health technology and biopharmaceutical sectors. Currently serving as Health Tech Counsel at Flanders Investment & Trade since October 2022, Ken expedites investment and R&D opportunities within the UK and Flemish ecosystems. As a Senior Consultant and Program Manager at Brinc, responsibilities include coordinating a team to implement a global MedTech and healthcare venture accelerator and sourcing deals from seed to pre-A rounds. Previous roles include Manager of Therapeutics at HKSTP, where Ken led a team in fostering growth for over 60 R&D-intensive companies, and Technology Liaison Officer at The Chinese University of Hong Kong, facilitating partnerships and portfolio management for various biomedical inventions. Ken's earlier experience also includes patent consulting and postdoctoral research in oncology and viral pharmacology. Educational qualifications include a Ph.D. in Biochemistry from Institut Pasteur Paris and ongoing studies in healthcare finance at MIT.